To what extent does Vyvanse (lisdexamfetamine) increase blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Pressure Effects of Vyvanse (Lisdexamfetamine)

Vyvanse (lisdexamfetamine) typically increases blood pressure by approximately 2 to 4 mmHg systolic and 1 to 3 mmHg diastolic, with concurrent increases in heart rate of about 3 to 6 beats per minute. 1

Mechanism and Magnitude of Blood Pressure Effects

Lisdexamfetamine, like other CNS stimulants, causes cardiovascular effects through its sympathomimetic activity. According to the FDA drug label, these effects include:

  • Mean increase in blood pressure of about 2-4 mmHg systolic and 1-3 mmHg diastolic 1
  • Mean increase in heart rate of about 3-6 beats per minute 1
  • These effects are consistent with high-quality evidence from a recent Cochrane review showing amphetamines increase systolic BP by 1.93 mmHg (95% CI 1.54 to 2.31) and diastolic BP by 1.84 mmHg (95% CI 1.51 to 2.16) 2

Patient-Specific Factors Affecting Blood Pressure Response

The cardiovascular effects of Vyvanse may vary based on:

  • Baseline blood pressure status: Patients with pre-existing hypertension may experience more significant increases
  • Age: Effects may be more pronounced in older adults
  • Dose: Higher doses generally correlate with greater cardiovascular effects
  • Duration of treatment: Evidence suggests these effects are sustained with long-term use 2

Monitoring Recommendations

Due to these cardiovascular effects, the FDA label recommends:

  • Monitor all patients taking Vyvanse for potential tachycardia and hypertension 1
  • More frequent monitoring is warranted for patients with:
    • Pre-existing hypertension
    • Cardiac disease
    • Advanced age

Clinical Significance and Risks

While the average blood pressure increase may seem modest:

  • These increases are sustained during treatment and normalize 1-2 days after discontinuation
  • Even small increases in blood pressure (2 mmHg systolic or 1 mmHg diastolic) can increase cardiovascular risk 3
  • Patients with borderline hypertension may cross into hypertensive range with Vyvanse treatment
  • The International Society of Hypertension lists sympathomimetics like amphetamines as medication exacerbators of hypertension 4

Comparison to Other Medications

  • Amphetamine compounds cause similar cardiovascular effects to other stimulants used for ADHD 5
  • In contrast, SSRIs like fluoxetine have minimal effects on blood pressure or may slightly reduce it 6
  • SNRIs cause an average increase of 2/1 mmHg in blood pressure, similar to but generally less than amphetamines 7

Important Precautions

  • Avoid use in patients with serious cardiac disease, structural cardiac abnormalities, cardiomyopathy, serious arrhythmias, or coronary artery disease 1
  • Use with caution in patients with pre-existing hypertension
  • Consider alternative treatments in patients at high cardiovascular risk

The blood pressure effects of Vyvanse, while modest in most patients, represent a clinically significant consideration that warrants appropriate monitoring and risk assessment, particularly in patients with pre-existing cardiovascular conditions.

References

Research

Effect of amphetamines on blood pressure.

The Cochrane database of systematic reviews, 2025

Research

Food and drug administration regulation of drugs that raise blood pressure.

Journal of cardiovascular pharmacology and therapeutics, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Blood pressure changes during short-term fluoxetine treatment.

Journal of clinical psychopharmacology, 1999

Guideline

Blood Pressure Effects of SNRIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.